1783 / 2063
ESTRO
2017
Molecular Imaging across the board
• Lung carcinoma: more accurate delineation of the NSCLC
GTV with FDG-PET
• Esophageal tumor: no convincing data for FDG-PET
• Brain tumor:
11
C-Met in low grade glioma and meningioma
• Rectal tumor: promising data with FDG-PET, but clinical
usefulness still unknown
• Cervix carcinoma: FDG-PET for delineation of mombo-
aortic node GTV
• Prostate carcinoma:
11
C-choline for recurrent disease; MRI
and DW-MRI for GTV delineation
ESTRO
2017
Could Molecular Imaging help identifying
tumour heterogeneity?